Skip to content
The Policy VaultThe Policy Vault

Xeljanz oral solution — Medica

All conditions

Initial criteria

  • Patient meets the standard Inflammatory Conditions – Xeljanz/XR Prior Authorization Policy criteria.

Reauthorization criteria

  • Patient continues to meet the standard Inflammatory Conditions – Xeljanz/XR Prior Authorization Policy criteria.

Approval duration

1 year or as directed